Hi guys,
Just briefly spoke to Matt regarding BTX 1308 trial and comparator drug and unfortunately he was heading into a meeting but said that yes, there will be more information to follow regarding this trial and extra data, but did also say that the design of this study was not to show efficacy but focus on method of action on a lesion...
I also asked him how to value BTX1801 as there is a private arrangement between us and UQ. He reassured me that UQ is just a contracer, we own the product and we own the data in full.
Hope this helps anyone who is wondering.....
Data to follow for BTX1308
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 32.0¢ | $1.776M | 5.339M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 118187 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 698385 | 8 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |